These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 30991286)

  • 1. Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis.
    Cai FF; Bian YQ; Wu R; Sun Y; Chen XL; Yang MD; Zhang QR; Hu Y; Sun MY; Su SB
    Biomed Pharmacother; 2019 Jun; 114():108863. PubMed ID: 30991286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of Chinese herbal medicine Yinchenhao Decoction on expressions of apoptosis-related genes in dimethylnitrosamine- or carbon tetrachloride-induced liver cirrhosis in rats].
    Sun MY; Wang L; Mu YP; Liu C; Bian YQ; Wang XN; Liu P
    Zhong Xi Yi Jie He Xue Bao; 2011 Apr; 9(4):423-34. PubMed ID: 21486556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yinchenhao decoction attenuates obstructive jaundice-induced liver injury and hepatocyte apoptosis by suppressing protein kinase RNA-like endoplasmic reticulum kinase-induced pathway.
    Wu YL; Li ZL; Zhang XB; Liu H
    World J Gastroenterol; 2019 Nov; 25(41):6205-6221. PubMed ID: 31749592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of Yinchenhao decoction in treating obstructive-jaundice-induced liver injury based on Nrf2 signaling pathway.
    Liu JJ; Xu Y; Chen S; Hao CF; Liang J; Li ZL
    World J Gastroenterol; 2022 Aug; 28(32):4635-4648. PubMed ID: 36157920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway.
    Cai FF; Wu R; Song YN; Xiong AZ; Chen XL; Yang MD; Yang L; Hu Y; Sun MY; Su SB
    Sci Rep; 2018 Oct; 8(1):15367. PubMed ID: 30337590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma.
    Chen Z; Lin T; Liao X; Li Z; Lin R; Qi X; Chen G; Sun L; Lin L
    Chin Med; 2021 Jan; 16(1):13. PubMed ID: 33478536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism for hepato-protective action of Liangxue Huayu Recipe (LHR): blockade of mitochondrial cytochrome c release and caspase activation.
    Jiang ZQ; Yan XJ; Bi L; Chen JP; Zhou Q; Chen WP
    J Ethnopharmacol; 2013 Jul; 148(3):851-60. PubMed ID: 23711831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis.
    Zhou Y; Wu R; Cai FF; Zhou WJ; Lu YY; Zhang H; Chen QL; Su SB
    J Ethnopharmacol; 2021 Jan; 264():113021. PubMed ID: 32479885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bioinformatics investigation into the pharmacological mechanisms of the effect of the Yinchenhao decoction on hepatitis C based on network pharmacology.
    Zhang J; Liu X; Wu J; Zhou W; Tian J; Guo S; Jia SS; Meng Z; Ni M
    BMC Complement Med Ther; 2020 Feb; 20(1):50. PubMed ID: 32050950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized therapeutic potential of Yinchenhao decoction for cholestatic hepatitis by combined network meta-analysis and network pharmacology.
    Luo S; Huang M; Lu X; Zhang M; Xiong H; Tan X; Deng X; Zhang W; Ma X; Zeng J; Efferth T
    Phytomedicine; 2024 Jul; 129():155573. PubMed ID: 38583348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Formula-syndrome correlation study of three classical anti-jaundice formulas in inhibition of liver fibrosis induced by dimethylnitrosamine in rats].
    Bian YQ; Ning BB; Cao HY; Lu Y; Liu C; Chen GF; Liu J; Liu P; Sun MY
    Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1405-12. PubMed ID: 23257134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis.
    Wu R; Dong S; Cai FF; Chen XL; Yang MD; Liu P; Su SB
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30669350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recipe-syndrome correlation and pathogenesis mechanism of Yinchenhao Decoction in intervening dimethylnitrosamine induced liver cirrhosis progress in rats].
    Liu C; Liu P; Tao Q
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Aug; 30(8):845-50. PubMed ID: 21038655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the active compounds and significant pathways of yinchenhao decoction based on network pharmacology.
    Huang J; Cheung F; Tan HY; Hong M; Wang N; Yang J; Feng Y; Zheng Q
    Mol Med Rep; 2017 Oct; 16(4):4583-4592. PubMed ID: 28791364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking.
    Bai YM; Liang S; Zhou B
    Aging (Albany NY); 2024 Feb; 16(4):3773-3789. PubMed ID: 38364259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
    Li H
    J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis.
    Jiang M; Huang C; Wu Q; Su Y; Wang X; Xuan Z; Wang Y; Xu F; Ge C
    J Ethnopharmacol; 2023 Mar; 303():115965. PubMed ID: 36460296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats.
    Tian H; Liu L; Li Z; Liu W; Sun Z; Xu Y; Wang S; Liang C; Hai Y; Feng Q; Zhao Y; Hu Y; Peng J
    J Ethnopharmacol; 2019 Mar; 232():227-235. PubMed ID: 30471378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis.
    Shi MJ; Yan XL; Dong BS; Yang WN; Su SB; Zhang H
    J Ethnopharmacol; 2020 May; 253():112689. PubMed ID: 32101775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis.
    Zhou Y; Wu R; Cai FF; Zhou WJ; Lu YY; Zhang H; Chen QL; Sun MY; Su SB
    Pharm Biol; 2021 Dec; 59(1):1594-1606. PubMed ID: 34808067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.